共 50 条
[41]
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors
[J].
Cassier, Philippe A.
;
Borad, Mitesh J.
;
Sharma, Sunil
;
Dubois, Bertrand
;
Caux, Christophe
;
Okano, Fumiyoshi
;
Von Hoff, Daniel D.
;
Blay, Jean-Yves
.
CANCER RESEARCH COMMUNICATIONS,
2025, 5 (07)
:1119-1128

Cassier, Philippe A.
论文数: 0 引用数: 0
h-index: 0
机构:
Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France
Ctr Rech Cancerol Lyon CRCL, Lyon, France Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Borad, Mitesh J.
论文数: 0 引用数: 0
h-index: 0
机构:
Mayo Clin Arizona, Mayo Clin, Dept Hematol Oncol, Comprehens Canc Ctr, Phoenix, AZ USA Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Sharma, Sunil
论文数: 0 引用数: 0
h-index: 0
机构:
HonorHlth Res Inst, Scottsdale, AZ USA Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Dubois, Bertrand
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Claude Bernard Lyon 1, Ctr Rech Cancerol Lyon CRCL, Ctr Leon Berard, Lyon Immunotherapy Canc Lab,INSERM U1052 CNRS UMR, Lyon, France Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Caux, Christophe
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Claude Bernard Lyon 1, Ctr Rech Cancerol Lyon CRCL, Ctr Leon Berard, Lyon Immunotherapy Canc Lab,INSERM U1052 CNRS UMR, Lyon, France Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Okano, Fumiyoshi
论文数: 0 引用数: 0
h-index: 0
机构:
Toray Industries Ltd, New Frontiers Res Labs, Kamakura, Japan Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Von Hoff, Daniel D.
论文数: 0 引用数: 0
h-index: 0
机构:
Translat Genom Res Inst TGen, Phoenix, AZ USA Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

Blay, Jean-Yves
论文数: 0 引用数: 0
h-index: 0
机构:
Ctr Leon Berard & Ctr Rech Cancerol Lyon CRCL, Dept Med Oncol, Lyon, France
Univ Claude Bernard Lyon 1, Lyon, France Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France
[42]
First-in-human (FIH) phase I study of RO7122290 (RO), a novel FAP-targeted 4-1BB agonist, administered as single agent and in combination with atezolizumab (ATZ) to patients with advanced solid tumours
[J].
Melero, I.
;
Sanmamed, M. F.
;
Calvo, E.
;
Moreno, I.
;
Moreno, V.
;
Hernandez Guerrero, T. C.
;
Martinez-Garcia, M.
;
Rodriguez-Vida, A.
;
Tabernero, J.
;
Azaro Pedrazzoli, A. B.
;
Spanggaard, I.
;
Rohrberg, K. S.
;
Guarin, E.
;
Nueesch, E.
;
Chesne, E.
;
Ceppi, M.
;
Sweere, U.
;
McIntyre, C.
;
Lichtenegger, F. S.
;
Krieter, O.
.
ANNALS OF ONCOLOGY,
2020, 31
:S707-S707

Melero, I.
论文数: 0 引用数: 0
h-index: 0
机构:
Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Sanmamed, M. F.
论文数: 0 引用数: 0
h-index: 0
机构:
Clin Univ Navarra, Dept Oncol, Pamplona, Spain Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Calvo, E.
论文数: 0 引用数: 0
h-index: 0
机构:
Ctr Integral Oncol Clara Campal, START Madrid, Med Oncol Dept, CIOCC, Madrid, Spain Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Moreno, I.
论文数: 0 引用数: 0
h-index: 0
机构:
Ctr Integral Oncol Clara Campal, START Madrid, Med Oncol Dept, CIOCC, Madrid, Spain Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Moreno, V.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Hosp Fdn Jimenez Diaz, START Madrid, Clin Res Phase & Trials Unit, FJD, Madrid, Spain Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Hernandez Guerrero, T. C.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Hosp Fdn Jimenez Diaz, START Madrid, Clin Res Phase & Trials Unit, FJD, Madrid, Spain Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Martinez-Garcia, M.
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp del Mar, CIBERONC, Med Oncol Dept, Barcelona, Spain Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Rodriguez-Vida, A.
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp del Mar, CIBERONC, Med Oncol Dept, Barcelona, Spain Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Tabernero, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Vall dHebron Inst Oncol VHIO, Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Azaro Pedrazzoli, A. B.
论文数: 0 引用数: 0
h-index: 0
机构:
Vall dHebron Inst Oncol VHIO, Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Spanggaard, I.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Copenhagen, Rigshosp, Dept Oncol, Copenhagen, Denmark Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Rohrberg, K. S.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Copenhagen, Rigshosp, Dept Oncol, Copenhagen, Denmark Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Guarin, E.
论文数: 0 引用数: 0
h-index: 0
机构:
Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev pRED, Basel, Switzerland Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Nueesch, E.
论文数: 0 引用数: 0
h-index: 0
机构:
Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev pRED, Basel, Switzerland Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Chesne, E.
论文数: 0 引用数: 0
h-index: 0
机构:
Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev pRED, Basel, Switzerland Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Ceppi, M.
论文数: 0 引用数: 0
h-index: 0
机构:
Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev pRED, Basel, Switzerland Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Sweere, U.
论文数: 0 引用数: 0
h-index: 0
机构:
Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev pRED, Basel, Switzerland Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

McIntyre, C.
论文数: 0 引用数: 0
h-index: 0
机构:
Roche Innovat Ctr Welwyn, Roche Pharma Res & Early Dev pRED, Welwyn Garden City, Herts, England Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Lichtenegger, F. S.
论文数: 0 引用数: 0
h-index: 0
机构:
Roche Innovat Ctr Munich, Roche Pharma Res & Early Dev pRED, Penzberg, Germany Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

Krieter, O.
论文数: 0 引用数: 0
h-index: 0
机构:
Roche Innovat Ctr Munich, Roche Pharma Res & Early Dev pRED, Penzberg, Germany Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain
[43]
Phase 1 study of SGN-BB228, an investigational CD228 x 4-1BB costimulatory antibody anticalin bispecific, in patients with advanced melanoma and other solid tumors (SGNBB228-001).
[J].
Henry, Jason Timothy
;
Mehnert, Janice M.
;
Rudnicki, Erika
;
Pinelli, Juan
;
Daud, Adil
.
JOURNAL OF CLINICAL ONCOLOGY,
2023, 41 (16)

Henry, Jason Timothy
论文数: 0 引用数: 0
h-index: 0
机构: HealthONE, Sarah Cannon Res Inst, Denver, CO USA

Mehnert, Janice M.
论文数: 0 引用数: 0
h-index: 0
机构: HealthONE, Sarah Cannon Res Inst, Denver, CO USA

Rudnicki, Erika
论文数: 0 引用数: 0
h-index: 0
机构: HealthONE, Sarah Cannon Res Inst, Denver, CO USA

Pinelli, Juan
论文数: 0 引用数: 0
h-index: 0
机构: HealthONE, Sarah Cannon Res Inst, Denver, CO USA

Daud, Adil
论文数: 0 引用数: 0
h-index: 0
机构: HealthONE, Sarah Cannon Res Inst, Denver, CO USA
[44]
A First-in-Human Phase I Study of GC1118, a Novel Anti-Epidermal Growth Factor Receptor Antibody, in Patients with Advanced Solid Tumors
[J].
Oh, Do-Youn
;
Lee, Keun-Wook
;
Han, Sae-Won
;
Kim, Jin Won
;
Shin, Jung-Won
;
Jo, Seong-Jin
;
Won, Jonghwa
;
Hahn, Seokyung
;
Lee, Howard
;
Kim, Woo Ho
;
Bang, Yung-Jue
.
ONCOLOGIST,
2019, 24 (08)
:1037-+

Oh, Do-Youn
论文数: 0 引用数: 0
h-index: 0
机构:
Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea

Lee, Keun-Wook
论文数: 0 引用数: 0
h-index: 0
机构:
Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Seongnam, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea

Han, Sae-Won
论文数: 0 引用数: 0
h-index: 0
机构:
Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea

Kim, Jin Won
论文数: 0 引用数: 0
h-index: 0
机构:
Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Seongnam, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea

Shin, Jung-Won
论文数: 0 引用数: 0
h-index: 0
机构:
Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Dermatol, Seongnam, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea

Jo, Seong-Jin
论文数: 0 引用数: 0
h-index: 0
机构:
Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Dermatol, Seoul, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea

Won, Jonghwa
论文数: 0 引用数: 0
h-index: 0
机构:
GC Pharma, Yongin, South Korea
Mogam Inst Biomed Res, Yongin, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea

Hahn, Seokyung
论文数: 0 引用数: 0
h-index: 0
机构:
Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Div Med Stat, Seoul, South Korea
Seoul Natl Univ, Dept Med, Coll Med, Seoul, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea

Lee, Howard
论文数: 0 引用数: 0
h-index: 0
机构:
Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Clin Pharmacol & Therapeut, Seoul, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea

Kim, Woo Ho
论文数: 0 引用数: 0
h-index: 0
机构:
Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Pathol, Seoul, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea

Bang, Yung-Jue
论文数: 0 引用数: 0
h-index: 0
机构:
Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea
[45]
Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1-4 inhibitor in patients with advanced solid tumors
[J].
Bahleda, R.
;
Meric-Bernstam, F.
;
Goyal, L.
;
Tran, B.
;
He, Y.
;
Yamamiya, I
;
Benhadji, K. A.
;
Matos, I
;
Arkenau, H-T
.
ANNALS OF ONCOLOGY,
2020, 31 (10)
:1405-1412

Bahleda, R.
论文数: 0 引用数: 0
h-index: 0
机构:
Gustave Roussy Canc Ctr, Early Drug Dev Dept DITEP, Villejuif, France Gustave Roussy Canc Ctr, Early Drug Dev Dept DITEP, Villejuif, France

Meric-Bernstam, F.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA Gustave Roussy Canc Ctr, Early Drug Dev Dept DITEP, Villejuif, France

Goyal, L.
论文数: 0 引用数: 0
h-index: 0
机构:
Massachusetts Gen Hosp, Ctr Canc, Dept Med Oncol, Boston, MA USA Gustave Roussy Canc Ctr, Early Drug Dev Dept DITEP, Villejuif, France

Tran, B.
论文数: 0 引用数: 0
h-index: 0
机构:
Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia Gustave Roussy Canc Ctr, Early Drug Dev Dept DITEP, Villejuif, France

He, Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Taiho Oncol Inc, Princeton, NJ USA Gustave Roussy Canc Ctr, Early Drug Dev Dept DITEP, Villejuif, France

Yamamiya, I
论文数: 0 引用数: 0
h-index: 0
机构:
Taiho Oncol Inc, Princeton, NJ USA Gustave Roussy Canc Ctr, Early Drug Dev Dept DITEP, Villejuif, France

Benhadji, K. A.
论文数: 0 引用数: 0
h-index: 0
机构:
Taiho Oncol Inc, Princeton, NJ USA Gustave Roussy Canc Ctr, Early Drug Dev Dept DITEP, Villejuif, France

Matos, I
论文数: 0 引用数: 0
h-index: 0
机构:
Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain Gustave Roussy Canc Ctr, Early Drug Dev Dept DITEP, Villejuif, France

Arkenau, H-T
论文数: 0 引用数: 0
h-index: 0
机构:
UCL, Sarah Cannon Res Inst, Med Oncol, London, England
UCL, Canc Inst, London, England Gustave Roussy Canc Ctr, Early Drug Dev Dept DITEP, Villejuif, France
[46]
A First-in-Human Phase I Monotherapy Study of RG7212 (R), a Novel Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Solid Tumors
[J].
Lassen, U.
;
Schellens, J. H. M.
;
Siu, L. L.
;
Jonker, D. J.
;
Sorensen, M.
;
Jarutat, T.
;
Wang, K.
;
Gehoe, D.
;
DeMario, M.
;
Goss, G.
.
EUROPEAN JOURNAL OF CANCER,
2012, 48
:12-12

Lassen, U.
论文数: 0 引用数: 0
h-index: 0
机构:
Rigshosp, Oncol Phase Unit 1, DK-2100 Copenhagen, Denmark Rigshosp, Oncol Phase Unit 1, DK-2100 Copenhagen, Denmark

Schellens, J. H. M.
论文数: 0 引用数: 0
h-index: 0
机构:
Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands Rigshosp, Oncol Phase Unit 1, DK-2100 Copenhagen, Denmark

Siu, L. L.
论文数: 0 引用数: 0
h-index: 0
机构:
Princess Margaret Hosp, Div Hematol & Med Oncol, Toronto, ON M4X 1K9, Canada Rigshosp, Oncol Phase Unit 1, DK-2100 Copenhagen, Denmark

Jonker, D. J.
论文数: 0 引用数: 0
h-index: 0
机构:
Ottawa Hosp Canc Ctr, Ottawa, ON, Canada Rigshosp, Oncol Phase Unit 1, DK-2100 Copenhagen, Denmark

Sorensen, M.
论文数: 0 引用数: 0
h-index: 0
机构:
Rigshosp, Oncol Phase Unit 1, DK-2100 Copenhagen, Denmark Rigshosp, Oncol Phase Unit 1, DK-2100 Copenhagen, Denmark

Jarutat, T.
论文数: 0 引用数: 0
h-index: 0
机构:
Hoffmann La Roche Inc, pRED, Penzberg, Germany Rigshosp, Oncol Phase Unit 1, DK-2100 Copenhagen, Denmark

Wang, K.
论文数: 0 引用数: 0
h-index: 0
机构:
Hoffmann La Roche Inc, Nutley, NJ 07110 USA Rigshosp, Oncol Phase Unit 1, DK-2100 Copenhagen, Denmark

Gehoe, D.
论文数: 0 引用数: 0
h-index: 0
机构:
Hoffmann La Roche Inc, Nutley, NJ 07110 USA Rigshosp, Oncol Phase Unit 1, DK-2100 Copenhagen, Denmark

DeMario, M.
论文数: 0 引用数: 0
h-index: 0
机构:
Hoffmann La Roche Inc, Nutley, NJ 07110 USA Rigshosp, Oncol Phase Unit 1, DK-2100 Copenhagen, Denmark

Goss, G.
论文数: 0 引用数: 0
h-index: 0
机构:
Ottawa Hosp Canc Ctr, Ottawa, ON, Canada Rigshosp, Oncol Phase Unit 1, DK-2100 Copenhagen, Denmark
[47]
A phase 1, dose escalation/dose-expansion study of QLF31907, a bispecific antibody (BsAb) targeting PD-L1 and 4-1BB, in patients with advanced solid tumors and lymphoma
[J].
Lin, Tongyu
;
Liu, Bin
;
Pu, Xingxiang
;
Wu, Lin
;
Du, Xiaobo
;
Mo, Ning
;
Song, Zhengbo
;
Zhou, Liwei
;
Duan, Xianlin
;
Zhu, Yanan
;
Kang, Xiaoyan
.
JOURNAL OF CLINICAL ONCOLOGY,
2024, 42 (16)

Lin, Tongyu
论文数: 0 引用数: 0
h-index: 0
机构: Univ Elect Sci & Technol China, Phase Clin Trial Ward Med Oncol Ctr 1, Sichuan Clin Res Ctr Canc,Affiliated Canc Hosp, Sichuan Canc Hosp & Inst,Sichuan Canc Ctr, Chengdu, Peoples R China

Liu, Bin
论文数: 0 引用数: 0
h-index: 0
机构: Univ Elect Sci & Technol China, Phase Clin Trial Ward Med Oncol Ctr 1, Sichuan Clin Res Ctr Canc,Affiliated Canc Hosp, Sichuan Canc Hosp & Inst,Sichuan Canc Ctr, Chengdu, Peoples R China

Pu, Xingxiang
论文数: 0 引用数: 0
h-index: 0
机构: Univ Elect Sci & Technol China, Phase Clin Trial Ward Med Oncol Ctr 1, Sichuan Clin Res Ctr Canc,Affiliated Canc Hosp, Sichuan Canc Hosp & Inst,Sichuan Canc Ctr, Chengdu, Peoples R China

Wu, Lin
论文数: 0 引用数: 0
h-index: 0
机构: Univ Elect Sci & Technol China, Phase Clin Trial Ward Med Oncol Ctr 1, Sichuan Clin Res Ctr Canc,Affiliated Canc Hosp, Sichuan Canc Hosp & Inst,Sichuan Canc Ctr, Chengdu, Peoples R China

Du, Xiaobo
论文数: 0 引用数: 0
h-index: 0
机构: Univ Elect Sci & Technol China, Phase Clin Trial Ward Med Oncol Ctr 1, Sichuan Clin Res Ctr Canc,Affiliated Canc Hosp, Sichuan Canc Hosp & Inst,Sichuan Canc Ctr, Chengdu, Peoples R China

Mo, Ning
论文数: 0 引用数: 0
h-index: 0
机构: Univ Elect Sci & Technol China, Phase Clin Trial Ward Med Oncol Ctr 1, Sichuan Clin Res Ctr Canc,Affiliated Canc Hosp, Sichuan Canc Hosp & Inst,Sichuan Canc Ctr, Chengdu, Peoples R China

Song, Zhengbo
论文数: 0 引用数: 0
h-index: 0
机构: Univ Elect Sci & Technol China, Phase Clin Trial Ward Med Oncol Ctr 1, Sichuan Clin Res Ctr Canc,Affiliated Canc Hosp, Sichuan Canc Hosp & Inst,Sichuan Canc Ctr, Chengdu, Peoples R China

Zhou, Liwei
论文数: 0 引用数: 0
h-index: 0
机构: Univ Elect Sci & Technol China, Phase Clin Trial Ward Med Oncol Ctr 1, Sichuan Clin Res Ctr Canc,Affiliated Canc Hosp, Sichuan Canc Hosp & Inst,Sichuan Canc Ctr, Chengdu, Peoples R China

Duan, Xianlin
论文数: 0 引用数: 0
h-index: 0
机构: Univ Elect Sci & Technol China, Phase Clin Trial Ward Med Oncol Ctr 1, Sichuan Clin Res Ctr Canc,Affiliated Canc Hosp, Sichuan Canc Hosp & Inst,Sichuan Canc Ctr, Chengdu, Peoples R China

Zhu, Yanan
论文数: 0 引用数: 0
h-index: 0
机构: Univ Elect Sci & Technol China, Phase Clin Trial Ward Med Oncol Ctr 1, Sichuan Clin Res Ctr Canc,Affiliated Canc Hosp, Sichuan Canc Hosp & Inst,Sichuan Canc Ctr, Chengdu, Peoples R China

Kang, Xiaoyan
论文数: 0 引用数: 0
h-index: 0
机构: Univ Elect Sci & Technol China, Phase Clin Trial Ward Med Oncol Ctr 1, Sichuan Clin Res Ctr Canc,Affiliated Canc Hosp, Sichuan Canc Hosp & Inst,Sichuan Canc Ctr, Chengdu, Peoples R China
[48]
First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors
[J].
Shitara, Kohei
;
Uehai, Satoshi
;
Shichino, Shigeyuki
;
Aoki, Hiroyasu
;
Ogiwara, Haru
;
Nakatsura, Tetsuya
;
Suzuki, Toshihiro
;
Shimomura, Manami
;
Yoshikawa, Toshiaki
;
Shoda, Kayoko
;
Kitano, Shigehisa
;
Yamashita, Makiko
;
Nakayama, Takayuki
;
Sato, Akihiro
;
Kuroda, Sakiko
;
Wakabayashi, Masashi
;
Nomura, Shogo
;
Yokochi, Shoji
;
Ito, Satoru
;
Matsushima, Kouji
;
Doi, Toshihiko
.
JOURNAL FOR IMMUNOTHERAPY OF CANCER,
2019, 7
:195

Shitara, Kohei
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

Uehai, Satoshi
论文数: 0 引用数: 0
h-index: 0
机构:
Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Regulat Inflammatory & Immune Dis, 2669 Yamazaki, Noda, Chiba 2780022, Japan
Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

Ogiwara, Haru
论文数: 0 引用数: 0
h-index: 0
机构:
Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Regulat Inflammatory & Immune Dis, 2669 Yamazaki, Noda, Chiba 2780022, Japan
Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

Nakatsura, Tetsuya
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr EPOC, Div Canc Immunetherapy, Chuo Ku, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

Suzuki, Toshihiro
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr EPOC, Div Canc Immunetherapy, Chuo Ku, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

Shimomura, Manami
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr EPOC, Div Canc Immunetherapy, Chuo Ku, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

Yoshikawa, Toshiaki
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr EPOC, Div Canc Immunetherapy, Chuo Ku, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

Shoda, Kayoko
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr EPOC, Div Canc Immunetherapy, Chuo Ku, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

Kitano, Shigehisa
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Expt Therapeut, Chuo Ku, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

Yamashita, Makiko
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Expt Therapeut, Chuo Ku, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

Nakayama, Takayuki
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr, Dept Expt Therapeut, Chuo Ku, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

Sato, Akihiro
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp East, Clin Res Support Off, Chiba, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

Kuroda, Sakiko
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp East, Clin Res Support Off, Chiba, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

Wakabayashi, Masashi
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp East, Clin Res Support Off, Chiba, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

Nomura, Shogo
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp East, Clin Res Support Off, Chiba, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

论文数: 引用数:
h-index:
机构:

Ito, Satoru
论文数: 0 引用数: 0
h-index: 0
机构:
Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Regulat Inflammatory & Immune Dis, 2669 Yamazaki, Noda, Chiba 2780022, Japan
IDAC Theranost Inc, Bunkyo Ku, Tokyo, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

论文数: 引用数:
h-index:
机构:

Doi, Toshihiko
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp East, Dept Expt Therapeut, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[49]
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
[J].
Teixeira, Luis
;
Medioni, Jacques
;
Garibal, Julie
;
Adotevi, Olivier
;
Doucet, Ludovic
;
Durey, Marie-Agnes Dragon
;
Ghrieb, Zineb
;
Kiladjian, Jean-Jacques
;
Brizard, Mara
;
Laheurte, Caroline
;
Wehbe, Maria
;
Pliquet, Elodie
;
Escande, Marie
;
Defrance, Remy
;
Culine, Stephane
;
Oudard, Stephane
;
Wain-Hobson, Simon
;
Doppler, Valerie
;
Huet, Thierry
;
Langlade-Demoyen, Pierre
.
CLINICAL CANCER RESEARCH,
2020, 26 (03)
:588-597

Teixeira, Luis
论文数: 0 引用数: 0
h-index: 0
机构:
Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Medioni, Jacques
论文数: 0 引用数: 0
h-index: 0
机构:
Paris Descartes Univ, Georges Pompidou Hosp, Ctr Early Clin Trials, Med Oncol Dept CEPEC, Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Garibal, Julie
论文数: 0 引用数: 0
h-index: 0
机构:
Invectys, Paris BioPk,12,Rue Jean Antoine de Baif, F-75013 Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Adotevi, Olivier
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Bourgogne Franche Comte, INSERM, EFS BFC, UMR1098,Biomonitoring Platform, Besancon, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Doucet, Ludovic
论文数: 0 引用数: 0
h-index: 0
机构:
Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Durey, Marie-Agnes Dragon
论文数: 0 引用数: 0
h-index: 0
机构:
Georges Pompidou Hosp, Immunobiol Lab, Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Ghrieb, Zineb
论文数: 0 引用数: 0
h-index: 0
机构:
Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Kiladjian, Jean-Jacques
论文数: 0 引用数: 0
h-index: 0
机构:
Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Brizard, Mara
论文数: 0 引用数: 0
h-index: 0
机构:
Paris Descartes Univ, Georges Pompidou Hosp, Ctr Early Clin Trials, Med Oncol Dept CEPEC, Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Laheurte, Caroline
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Bourgogne Franche Comte, INSERM, EFS BFC, UMR1098,Biomonitoring Platform, Besancon, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Wehbe, Maria
论文数: 0 引用数: 0
h-index: 0
机构:
Invectys, Paris BioPk,12,Rue Jean Antoine de Baif, F-75013 Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Pliquet, Elodie
论文数: 0 引用数: 0
h-index: 0
机构:
Invectys, Paris BioPk,12,Rue Jean Antoine de Baif, F-75013 Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Escande, Marie
论文数: 0 引用数: 0
h-index: 0
机构:
Invectys, Paris BioPk,12,Rue Jean Antoine de Baif, F-75013 Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Defrance, Remy
论文数: 0 引用数: 0
h-index: 0
机构:
Invectys, Paris BioPk,12,Rue Jean Antoine de Baif, F-75013 Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Culine, Stephane
论文数: 0 引用数: 0
h-index: 0
机构:
Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Oudard, Stephane
论文数: 0 引用数: 0
h-index: 0
机构:
Paris Descartes Univ, Georges Pompidou Hosp, Ctr Early Clin Trials, Med Oncol Dept CEPEC, Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Wain-Hobson, Simon
论文数: 0 引用数: 0
h-index: 0
机构:
Invectys, Paris BioPk,12,Rue Jean Antoine de Baif, F-75013 Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Doppler, Valerie
论文数: 0 引用数: 0
h-index: 0
机构:
Invectys, Paris BioPk,12,Rue Jean Antoine de Baif, F-75013 Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Huet, Thierry
论文数: 0 引用数: 0
h-index: 0
机构:
Invectys, Paris BioPk,12,Rue Jean Antoine de Baif, F-75013 Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France

Langlade-Demoyen, Pierre
论文数: 0 引用数: 0
h-index: 0
机构:
Invectys, Paris BioPk,12,Rue Jean Antoine de Baif, F-75013 Paris, France Paris Univ, St Louis Hosp, AP HP, Breast Dis Unit,HIPI INSERM U976, Paris, France
[50]
First-in-human dose escalation and expansion study of SYSA1801, an antibody-drug conjugate targeting claudin 18.2 in patients with resistant/refractory solid tumors
[J].
Wang, Yakun
;
Gong, Jifang
;
Lin, Rongbo
;
Zhao, Shen
;
Wang, Jufeng
;
Wang, Qianli
;
Zhang, Yanqiao
;
Su, Dan
;
Zhang, Jingdong
;
Dong, Qian
;
Lin, Ling
;
Tian, Wen
;
Chen, Ying
;
Yang, Yang
;
Zhang, Xueyuan
;
Wan, Xuechao
;
Gao, Jinfeng
;
An, Na
;
Jansen, Valerie Malyvanh
;
Shen, Lin
.
JOURNAL OF CLINICAL ONCOLOGY,
2023, 41 (16)

Wang, Yakun
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Gong, Jifang
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Lin, Rongbo
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Zhao, Shen
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Wang, Jufeng
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Wang, Qianli
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Zhang, Yanqiao
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Su, Dan
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Zhang, Jingdong
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Dong, Qian
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Lin, Ling
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Tian, Wen
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Chen, Ying
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Yang, Yang
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Zhang, Xueyuan
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Wan, Xuechao
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Gao, Jinfeng
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

An, Na
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Jansen, Valerie Malyvanh
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

Shen, Lin
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China